HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Equity Capital Markets

Betters Medical Investment Holdings / Equity Capital Markets

<ul>
<li>The MWA market that Betters belongs to has showed rapid growth and large potential. Obviously, Betters would benefit from it based on its existing products and leading market position.</li>
<li>However, the medical device industry in China is subject to strict policy supervision. It cannot rule out the possibility that the Company’s products would be included in the centralized procurement.</li>
<li>In terms of valuation, <a href="https://www.smartkarma.com/entities/micro-tech-nanjing-co-ltd" target="_blank" data-smartkarma-citation="entities:30320:1" rel="noopener">Micro-Tech Nanjing Co Ltd (688029 CH)</a> could be a comparable company,  but Betters' valuation should be lower than it.</li>
</ul>


The MWA market that Betters belongs to has showed rapid growth and large potential. Obviously, Betters would benefit from it based on its existing products and leading market position.
However, the medical device industry in China is subject to strict policy supervision. It cannot rule out the possibility that the Company’s products would be included in the centralized procurement.
In terms of valuation, Micro-Tech Nanjing Co Ltd (688029 CH) could be a comparable company,  but Betters' valuation should be lower than it.


Pre-IPO Betters Medical Investment Holdings - The Industry, the Business and the Concerns

Hong Kong

Betters Medical Investment Holdings (BMI HK)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Pre-IPO Betters Medical Investment Holdings - The Industry, the Business and the Concerns

The MWA market has great potential and Betters also has leading position.The future potential centralized procurement could be a concern for...

Xinyao (Criss) Wang